By Kate Kelland LONDON, Jan 30 (Reuters) - A major analysis of one of the world's most fiercely disputed medicines, Roche's Tamiflu, has found it cuts flu symptoms by a day and can help some patients avoid hospital treatment and complications. Published in The Lancet on Friday, the pooled analysis included data from all previously published and unpublished trials of Tamiflu, which has been the subject of intense scientific debate for years. The drug, known generically as oseltamivir, is an anti-viral which was stockpiled and widely used by governments during the 2009/2010 H1N1 "swine flu" pandemic. It is approved by regulators worldwide and is on the World Health Organization's "essential medicines" list.
via Health News Headlines - Yahoo News http://ift.tt/1vbVwJw
No comments:
Post a Comment